Acute promyelocytic leukemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Acute promyelocytic leukemia Classification and external resources | |
| ICD-10 | C92.4 |
|---|---|
| ICD-9 | 205.0 |
| ICD-O: | M9866/3 |
| OMIM | 102578 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Acute promyelocytic leukemia is a subtype of acute myelogenous leukemia (AML), a cancer of the blood and bone marrow. It is also known as acute progranulocytic leukemia; APL; AML with t(15;17)(q22;q12), PML-RARA and variants; FAB subtype M3 and M3 variant.
In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is unique from other forms of AML in its responsiveness to all trans retinoic acid (ATRA) therapy.
Signs and symptoms
Signs and symptoms of acute promyelocytic leukemia are similar to other forms of AML. Symptoms include fever, fatigue, weight loss or loss of appetite, shortness of breath with exertion, anemia, easy bruising or bleeding, petechiae (flat, pin-head sized spots under the skin caused by bleeding), bone pain and joint pain and persistent or frequent infections.[8]
The accumulation of promyelocytes in the bone marrow results in a reduction in the production of normal red blood cells and platelets resulting in anemia and thrombocytopenia. Either leukopenia (low white cell count) or leukocytosis (high white cell count) may be observed in the peripheral blood.
Symptoms include:
- Fatigue, weakness, shortness of breath (from anemia)
- Easy bruising and bleeding (from thrombocytopenia and coagulopathy)
- Fever and infection (from lack of normal white blood cells)
In addition, acute promyelocytic leukemia is frequently associated with bleeding caused by disseminated intravascular coagulation (DIC).
Epidemiology
Acute promyelocytic leukemia represents 5-8% of AML in adults. The median age is approximately 40 years, which is considerably younger than the other subtypes of AML (70 years). The incidence is increased in patients originated in Latin American countries.(Douer et al.)
Pathogenesis
Acute promyelocytic leukemia is characterized by chromosomal translocation involving the retinoic acid receptor-alpha gene on chromosome 17 (RARα). In 95% of cases of APL, retinoic acid receptor-alpha (RARα) gene on chromosome 17 is involved in a reciprocal translocation with the promyelocytic leukemia gene (PML) on chromosome 15, a translocation denoted as t(15;17)(q22;q12).
Four other gene rearrangements have been described in APL fusing RARα to promyelocytic leukemia zinc finger (PLZF), nucleophosmin (NPM), nuclear matrix associated (NUMA), or signal transducer and activator of transcription 5b (STAT5B) genes.
The resultant fusion proteins disrupt the function of RARα which blocks the normal maturation of granulocytes. Although the chromosomal translocation involving RARα is believed to be the initiating event, additional mutations are required for the development of leukemia.
Diagnosis
Acute promyelocytic leukemia can be distinguished from other types of AML based on morphologic examination of a bone marrow biopsy or aspirate. Definitive diagnosis requires testing for the RARα fusion gene. This may be done by polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), or conventional cytogenetics of peripheral blood or bone marrow.
Monitoring for relapse using PCR tests for RARα allows early re-treatment which is successful in many instances.
Treatment
APL is unique among the leukemias distinguished by its sensitivity to all-trans retinoic acid (ATRA), a derivative of vitamin A. Treatment with ATRA causes differentiation of the immature leukemic promyelocytes into mature granulocytes. ATRA is typically combined with anthracycline based chemotherapy resulting in a clinical remission in approximately 90% of patients.
ATRA therapy is associated with the unique side effect of retinoic acid syndrome. This is associated with the development of dyspnea, fever, weight gain, peripheral edema and is treated with dexamethasone. The etiology of retinoic acid syndrome has been attributed to capillary leak syndrome from cytokine release from the differentiating promyelocytes.
Treatment options for patients with relapsed disease include arsenic trioxide and allogeneic stem cell transplant.
References
- Kumar, Vinay, Abul Abbas, and Nelson Fausto. Robbins and Cotran Pathologic Basis of Disease, 7th ed. (2004). ISBN 81-8147-528-3
- Sacher, Ronald A. and Richard A. McPherson. Wildman's Clinical Interpretation of Laboratory Tests, 11th ed. (2000). ISBN 0-8036-0270-7
- Dan Douer, et al. British Journal of Haematology, vol. 122, pp. 563, Aug. 2003
- Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide, N Engl J Med. 1998 Nov 5;339(19):1341-8.
External Links
- http://www.trisenox.com/
- ACUTE MYELOID LEUKEMIA IN ADULTS [3]
- The character Kate in "My Sister's Keeper" by Jodi Picoult has APL
WikiDoc Research Resources for Acute promyelocytic leukemia | |
|---|---|
| Articles on Acute promyelocytic leukemia | Most recent articles on Acute promyelocytic leukemia • Most cited articles on Acute promyelocytic leukemia • Review articles on Acute promyelocytic leukemia • Articles on Acute promyelocytic leukemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Acute promyelocytic leukemia | Powerpoint slides on Acute promyelocytic leukemia • Images of Acute promyelocytic leukemia • Photos of Acute promyelocytic leukemia • Podcasts & MP3s on Acute promyelocytic leukemia • Videos on Acute promyelocytic leukemia |
| Evidence Based Medicine Regarding Acute promyelocytic leukemia | Cochrane Collaboration on Acute promyelocytic leukemia • Bandolier on Acute promyelocytic leukemia • TRIP on Acute promyelocytic leukemia |
| Cost Effectiveness of Acute promyelocytic leukemia | Cost Effectiveness of Acute promyelocytic leukemia |
| Clinical Trials Involving Acute promyelocytic leukemia | Ongoing Trials on Acute promyelocytic leukemia at Clinical Trials.gov • Trial results on Acute promyelocytic leukemia • Clinical Trials on Acute promyelocytic leukemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Acute promyelocytic leukemia | US National Guidelines Clearinghouse on Acute promyelocytic leukemia • NICE Guidance on Acute promyelocytic leukemia • NHS PRODIGY Guidance • FDA on Acute promyelocytic leukemia • CDC on Acute promyelocytic leukemia |
| Textbook Information on Acute promyelocytic leukemia | Books and Textbook Information on Acute promyelocytic leukemia |
| Pharmacology Resources on Acute promyelocytic leukemia | Dosing of Acute promyelocytic leukemia • Drug interactions with Acute promyelocytic leukemia • Side effects of Acute promyelocytic leukemia • Allergic reactions to Acute promyelocytic leukemia • Overdose information on Acute promyelocytic leukemia • Carcinogenicity information on Acute promyelocytic leukemia • Acute promyelocytic leukemia in pregnancy • Pharmacokinetics of Acute promyelocytic leukemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Acute promyelocytic leukemia | Genetics of Acute promyelocytic leukemia • Pharmacogenomics of Acute promyelocytic leukemia • Proteomics of Acute promyelocytic leukemia |
| Newstories on Acute promyelocytic leukemia | Acute promyelocytic leukemia in the news • Be alerted to news on Acute promyelocytic leukemia • News trends on Acute promyelocytic leukemia |
| Commentary on Acute promyelocytic leukemia | Blogs on Acute promyelocytic leukemia |
| Patient Resources on Acute promyelocytic leukemia | Patient resources on Acute promyelocytic leukemia • Discussion groups on Acute promyelocytic leukemia • Patient Handouts on Acute promyelocytic leukemia • Directions to Hospitals Treating Acute promyelocytic leukemia • Risk calculators and risk factors for Acute promyelocytic leukemia |
| Healthcare Provider Resources on Acute promyelocytic leukemia | Symptoms of Acute promyelocytic leukemia • Causes & Risk Factors for Acute promyelocytic leukemia • Diagnostic studies for Acute promyelocytic leukemia • Treatment of Acute promyelocytic leukemia |
| Continuing Medical Education (CME) Programs on Acute promyelocytic leukemia | CME Programs on Acute promyelocytic leukemia |
| International Resources on Acute promyelocytic leukemia | Acute promyelocytic leukemia en Espanol • Acute promyelocytic leukemia en Francais |
| Business Resources on Acute promyelocytic leukemia | Acute promyelocytic leukemia in the Marketplace • Patents on Acute promyelocytic leukemia |
| Informatics Resources on Acute promyelocytic leukemia | List of terms related to Acute promyelocytic leukemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
